DSGN Reports $222.8M Cash, $17.6M Net Loss, Adds Board Member, Advances FA Trial, Pipeline Updates
Design Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $10.44
+23% in 1d after detection
Post-detection moves
1h
—
1d
+23%
3d
+3.8%
7d
+10%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS